# Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis

> **NCT05906615** · PHASE2 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 30 (actual)

## Conditions studied

- Pancreatic Cancer
- Chronic Pancreatitis

## Interventions

- **DRUG:** Lidocaine IV

## Key facts

- **NCT ID:** NCT05906615
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-14
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05906615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05906615, "Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05906615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*